Alphabet's Google Life Sciences has been shaking
things up this year, forging ahead with a series of med-tech related
projects with new leadership in tow. In the spinoff's latest move, it's
unveiling a name change.
Google Life Sciences will now be known as "Verily,"
a word with 13th century Middle English origins that means "truly" or
"certainly." The company is shooting for an aspirational message with
its new name, CEO Andy Conrad told STAT. Verily
wants to take conventional medical technologies "from reactive to
proactive, from intervention to prevention," Conrad said. "Only through
the truth are we going to defeat Mother Nature."
Meanwhile, Verily is dialing up its med-tech cachet
with big plans for innovation. The Mountain View, CA-based company is
developing "smart" contact lenses with Swiss drugmaker Novartis ($NVS),
and the pair plan to test a first prototype of the product on humans in
2016. Verily recently secured two patents for new technology, one for a
laser ablation system and another for a needle-free blood draw device.
For further information, please click here.
No comments:
Post a Comment